These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 31162629)
1. Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers. Hachad H; Ramsey LB; Scott SA Clin Pharmacol Ther; 2019 Aug; 106(2):298-301. PubMed ID: 31162629 [No Abstract] [Full Text] [Related]
2. Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic? Huddart R; Sangkuhl K; Whirl-Carrillo M; Klein TE Clin Pharmacol Ther; 2019 Aug; 106(2):284-286. PubMed ID: 30977517 [No Abstract] [Full Text] [Related]
3. Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx). Picard N; Boyer JC; Etienne-Grimaldi MC; Barin-Le Guellec C; Thomas F; Loriot MA; Therapie; 2017 Apr; 72(2):185-192. PubMed ID: 28237406 [TBL] [Abstract][Full Text] [Related]
4. The challenges of implementing pharmacogenomic testing in the clinic. Moyer AM; Caraballo PJ Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250 [TBL] [Abstract][Full Text] [Related]
5. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing. van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729 [TBL] [Abstract][Full Text] [Related]
6. The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting. Cavallari LH; Beitelshees AL; Blake KV; Dressler LG; Duarte JD; Elsey A; Eichmeyer JN; Empey PE; Franciosi JP; Hicks JK; Holmes AM; Jeng L; Lee CR; Lima JJ; Limdi NA; Modlin J; Obeng AO; Petry N; Pratt VM; Skaar TC; Tuteja S; Voora D; Wagner M; Weitzel KW; Wilke RA; Peterson JF; Johnson JA Clin Transl Sci; 2017 May; 10(3):143-146. PubMed ID: 28294551 [No Abstract] [Full Text] [Related]
7. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions. Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539 [TBL] [Abstract][Full Text] [Related]
8. Application of pharmacogenetics in clinical practice: problems and solutions. Baskys A J Neural Transm (Vienna); 2019 Jan; 126(1):109-113. PubMed ID: 29922908 [TBL] [Abstract][Full Text] [Related]
9. An optimized prediction framework to assess the functional impact of pharmacogenetic variants. Zhou Y; Mkrtchian S; Kumondai M; Hiratsuka M; Lauschke VM Pharmacogenomics J; 2019 Apr; 19(2):115-126. PubMed ID: 30206299 [TBL] [Abstract][Full Text] [Related]
10. Use of a multi-gene pharmacogenetic panel reduces adverse drug effects. Cavallari LH; Johnson JA Cell Rep Med; 2023 May; 4(5):101021. PubMed ID: 37084734 [TBL] [Abstract][Full Text] [Related]
12. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs. Theken KN; Lee CR; Gong L; Caudle KE; Formea CM; Gaedigk A; Klein TE; Agúndez JAG; Grosser T Clin Pharmacol Ther; 2020 Aug; 108(2):191-200. PubMed ID: 32189324 [TBL] [Abstract][Full Text] [Related]
13. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation. Cecchin E; De Mattia E; Ecca F; Toffoli G Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835 [TBL] [Abstract][Full Text] [Related]
14. Feasibility and implementation of CYP2C19 genotyping in patients using antiplatelet therapy. Bergmeijer TO; Vos GJ; Claassens DM; Janssen PW; Harms R; der Heide RV; Asselbergs FW; Ten Berg JM; Deneer VH Pharmacogenomics; 2018 May; 19(7):621-628. PubMed ID: 29701129 [TBL] [Abstract][Full Text] [Related]
15. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward. Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacogenetics in daily practice]. van Gelder T; van Schaik RHN Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32608920 [TBL] [Abstract][Full Text] [Related]
17. The Routine Clinical use of Pharmacogenetic Tests: What it Will Require? Dias MM; Sorich MJ; Rowland A; Wiese MD; McKinnon RA Pharm Res; 2017 Aug; 34(8):1544-1550. PubMed ID: 28236061 [TBL] [Abstract][Full Text] [Related]
18. Attitudes of clinicians following large-scale pharmacogenomics implementation. Peterson JF; Field JR; Shi Y; Schildcrout JS; Denny JC; McGregor TL; Van Driest SL; Pulley JM; Lubin IM; Laposata M; Roden DM; Clayton EW Pharmacogenomics J; 2016 Aug; 16(4):393-8. PubMed ID: 26261062 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients. Qin W; Du Z; Xiao J; Duan H; Shu Q; Li H Pharmacogenomics; 2020 Feb; 21(3):209-219. PubMed ID: 31967514 [No Abstract] [Full Text] [Related] [Next] [New Search]